Steven Lovejoy, MD | |
3601 Tvc, Nashville, TN 37232-5100 | |
(615) 322-3000 | |
Not Available |
Full Name | Steven Lovejoy |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
Location | 3601 Tvc, Nashville, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144317272 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MD40489 (Tennessee) | Secondary |
207XP3100X | Orthopaedic Surgery - Pediatric Orthopaedic Surgery | MD40489 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Steven Lovejoy, MD Mce South Tower Ste 4200, Nashville, TN 37232-8774 Ph: (615) 322-3000 | Steven Lovejoy, MD 3601 Tvc, Nashville, TN 37232-5100 Ph: (615) 322-3000 |
News Archive
Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings.
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Dr. Christian Torp-Pedersen is scheduled to present detailed findings from the Phase 2b clinical trial of vernakalant (oral) at the European Society of Cardiology (ESC) Congress 2009, being held in Barcelona, Spain from August 29 to September 2, 2009.
Not all cancer cells within a tumor are created equal; nor do all immune cells (or all liver or brain cells) in your body have the same job. Much of their function depends on their location.
A new bioRxiv study by a research group from the University of California Irvine shows in vitro activity and non-toxicity of the first-in-class cyclic peptide that inhibits the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – laying the groundwork for its use in the treatment of coronavirus disease (COVID-19).
Basal cell carcinoma is one of the most common cancers and its incidence is increasing worldwide, putting a significant burden on health services. Topical treatments are available for superficial basal cell carcinoma (BCC) but there has a lack of long-term follow-up data to guide treatment decisions.
› Verified 6 days ago
Dr. Robert Joel Otto, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203 Phone: 615-342-0038 | |
James Hardman Rubright, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 345 23rd Ave N, Suite 212, Nashville, TN 37203 Phone: 615-963-9200 Fax: 615-963-9201 | |
Alexander David Savage, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203 Phone: 615-342-0038 | |
William Edward Carpenter, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8 City Blvd Ste 300, Nashville, TN 37209 Phone: 615-823-8891 Fax: 615-321-6226 | |
Daniel Nuri Kiridly, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3443 Dickerson Pike Ste 190, Nashville, TN 37207 Phone: 615-860-1580 | |
Dr. Chelsea Brown, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Dr. Jane Merideth Siegel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 21st Ave N, Nashville, TN 37203 Phone: 615-329-6600 Fax: 615-695-1483 |